Day & Ennis, LLC
- SEC CIK
- 0001535677
- Latest filing
- Jan 18, 2024
ABT holding history
Abbott Laboratories in every 13F filed by Day & Ennis, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q4 2023 holdings
- Shares (Q4 2023)
- 8,691
- Value
- $956.6K
- % of portfolio
- 0.3%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 8,691 | $956.6K | 0.3% | +40.0% | Added | Holders |
| Q3 2023 | 8,687 | $841.3K | 0.3% | +5+0.1% | Added | Holders |
| Q2 2023 | 8,682 | $946.6K | 0.4% | +40.0% | Added | Holders |
| Q1 2023 | 8,678 | $878.8K | 0.3% | +40.0% | Added | Holders |
| Q4 2022 | 8,674 | $952.3K | 0.4% | +183+2.2% | Added | Holders |
| Q3 2022 | 8,491 | $822.0K | 0.3% | −97−1.1% | Reduced | Holders |
| Q2 2022 | 8,588 | $933.0K | 0.4% | +104+1.2% | Added | Holders |
| Q1 2022 | 8,484 | $1.00M | 0.3% | −19−0.2% | Reduced | Holders |
| Q4 2021 | 8,503 | $1.20M | 0.4% | +30.0% | Added | Holders |
| Q3 2021 | 8,500 | $1.00M | 0.3% | −721−7.8% | Reduced | Holders |
| Q2 2021 | 9,221 | $1.07M | 0.4% | +727+8.6% | Added | Holders |
| Q1 2021 | 8,494 | $1.02M | 0.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.